Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 72 citing articles:

Combinatorial, Microparticle-Based Delivery of Immune Modulators Reprograms the Dendritic Cell Phenotype and Promotes Remission of Collagen-Induced Arthritis in Mice
Riley Allen, Shahab Chizari, A. Jeffrey, et al.
ACS Applied Bio Materials (2019) Vol. 2, Iss. 6, pp. 2388-2404
Closed Access | Times Cited: 37
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 Diabetes
Alexander J. Kwiatkowski, Joshua M. Stewart, Jonathan Cho, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 11
Open Access | Times Cited: 34
Local delivery strategies to restore immune homeostasis in the context of inflammation
Elizabeth R. Bentley, Steven R. Little
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113971-113971
Open Access | Times Cited: 28
A comparison between optimized PLGA and CS-Alg-PLGA microspheres for long-lasting release of glatiramer acetate
Maedeh Hajian, Vahid Erfani‐Moghadam, Mehdi Sheikh Arabi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104355-104355
Closed Access | Times Cited: 12
Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy
Qi Liu, Guoqiang Chen, Xingchi Liu, et al.
ACS Nano (2024)
Open Access | Times Cited: 4
Immunostimulation and Immunosuppression: Nanotechnology on the Brink
Flavia Fontana, Patrícia Figueiredo, Tomás Bauleth‐Ramos, et al.
Small Methods (2018) Vol. 2, Iss. 5
Closed Access | Times Cited: 37
Engineering Biomaterials to Direct Innate Immunity
Robert S. Oakes, Eugene Froimchuk, Christopher M. Jewell
Advanced Therapeutics (2019) Vol. 2, Iss. 6
Open Access | Times Cited: 34
Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants
Ying Li, Anthony W. Frei, Irayme M. Labrada, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis
Niloufar Rahiman, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 620-644
Closed Access | Times Cited: 16
Vaccines for immune tolerance against autoimmune disease
April Kim, Fang Xie, Omar A. Abed, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115140-115140
Open Access | Times Cited: 10
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Ariane Mwema, Giulio G. Muccioli, Anne des Rieux
Journal of Controlled Release (2023) Vol. 364, pp. 435-457
Closed Access | Times Cited: 9
Administration of ROS-Scavenging Cerium Oxide Nanoparticles Simply Mixed with Autoantigenic Peptides Induce Antigen-Specific Immune Tolerance against Autoimmune Encephalomyelitis
Thanh Loc Nguyen, Ngoc Man Phan, Jaeyun Kim
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 26, pp. 33106-33120
Closed Access | Times Cited: 3
Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends
Lixia Gao, Li Wang, Elena Woo, et al.
Clinical Reviews in Allergy & Immunology (2019) Vol. 59, Iss. 2, pp. 175-194
Closed Access | Times Cited: 29
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
Olga Kammona, Costas Kiparissides
Brain Sciences (2020) Vol. 10, Iss. 6, pp. 333-333
Open Access | Times Cited: 26
Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity
Marian A. Ackun‐Farmmer, Christopher M. Jewell
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 8
Cell and biomaterial delivery strategies to induce immune tolerance
Brianna L. Scotland, Jacob R. Shaw, Shruti Dharmaraj, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115141-115141
Open Access | Times Cited: 8
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
Maigan A. Brusko, Joshua M. Stewart, Amanda L. Posgai, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 22
Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All-trans Retinoic Acid and Transforming Growth Factor Beta-1 Single Microparticle Formulation
Brett E. Phillips, Yésica Garciafigueroa, Carl Engman, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation
Yang Yang, Pere Santamaría
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113898-113898
Open Access | Times Cited: 18
Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice
Alexander J. Kwiatkowski, Eric Y. Helm, Joshua M. Stewart, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 43
Open Access | Times Cited: 13
Harnessing Immunomodulatory Polymers for Treatment of Autoimmunity, Allergy, and Transplant Rejection
Allen B. Tu, G Krishna, Kevin R. Smith, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 415-440
Closed Access | Times Cited: 2
Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance
Yuan Rui, Haleigh B. Eppler, Alexis A. Yanes, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 11
Localized hydrogel delivery of dendritic cells for attenuation of multiple sclerosis in a murine model
Aline M. Thomas, Nicholas M. Beskid, Lori Blanchfield, et al.
Journal of Biomedical Materials Research Part A (2020) Vol. 109, Iss. 7, pp. 1247-1255
Open Access | Times Cited: 17
Robust tolerogenic dendritic cells via push/pull pairing of toll-like-receptor agonists and immunomodulators reduces EAE
Peter E. Deak, Hannah Riley Knight, Aaron P. Esser‐Kahn
Biomaterials (2022) Vol. 286, pp. 121571-121571
Open Access | Times Cited: 10
Nanoparticle dose and antigen loading attenuate antigen‐specific T‐cell responses
Liam M. Casey, Joseph T. Decker, Joseph R. Podojil, et al.
Biotechnology and Bioengineering (2022) Vol. 120, Iss. 1, pp. 284-296
Open Access | Times Cited: 10

Scroll to top